. Author manuscript; available in PMC: 2013 Nov 18.

Published in final edited form as: Psychiatr Serv. 2009 Jun;60(6):10.1176/appi.ps.60.6.823. doi: 10.1176/appi.ps.60.6.823

Table 3. Significant Demographic and Clinical Predictors ofReceiving Specific Treatments Among Patients With Panic Disorder With or Without Agoraphobia^a.

Treatment	Overall χ²	Predictor	β	Wald χ²	Odds Ratio	95% CI
Medication	53.58^***	Caucasian	1.01	4.64^*	2.74	1.10 to 6.87
		Agoraphobia	1.17	13 29^***	3.24	1.72 to 6.08
		Major depressive disorder	.70	4.41^*	2.02	1.05 to 3.91
Psychotherapy	26.58^*	Medicare/Medicaid/Public assistance	1.43	5.08^*	4.18	1.21 to 14.49
Concurrent medication and therapy	36.62^**	4-year college degree or more	1.61	5.32^*	5.02	1.28 to 19.78

All analyses included the following predictors: age, gender, race/ethnicity (Non-Hispanic Caucasian or other), marital status (never married, married, or separated/divorced/widowed), education (less than high school graduate, high school graduate, some college/associate’s degree, or at least a 4-year college degree or more), insurance status (none, Medicare/Medicaid/Public assistance, private, or both Medicare/Medicaid/Public assistance and private), presence of agoraphobia, age of panic disorder onset, number of comorbid anxiety disorders, and current major depressive disorder. Only significant predictors are shown. For all analyses, df=15.

p<.05

^**

p<01

^***

p<.001

Table 3. Significant Demographic and Clinical Predictors ofReceiving Specific Treatments Among Patients With Panic Disorder With or Without Agoraphobiaa.

Table 3. Significant Demographic and Clinical Predictors ofReceiving Specific Treatments Among Patients With Panic Disorder With or Without Agoraphobia^a.